| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
hCG beta Peptide Blocking Peptide is synthetically produced from the 142-165 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Dilution Range: |
WB: IP: 1:200IHC: 1:250ICC: 1:250IF: 1:250 |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
CGB1 |
| Gene ID: |
114335 |
| Uniprot ID: |
CGB1_HUMAN |
| Immunogen Region: |
142-165 |
| Immunogen: |
Synthetic peptide taken within amino acid region 142-165 on human Chorionic gonaotropin beta protein. |
| Tissue Specificity | Expressed in placenta, testis and pituitary. |
| Peptide Name | Choriogonadotropin Subunit Beta Variant 1 |
| Cellular Localisation | Secreted |
| Alternative Peptide Names | Choriogonadotropin Subunit Beta Variant 1 proteinCGB1 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
